Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Synaptotagmin 1 ELISA Kit (AC3282)
Cat.#: ASET-1871
Specifications
Description Mouse Synaptotagmin 1 ELISA Kit allows for the in vitro quantitative determination of mouse Synaptotagmin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2056 Bovine Insulin ELISA Kit (AC3467) Quantitative inquiry ASET-1484 Mouse alpha Synuclein ELISA Kit (AC2895) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-2441 Camel Insulin ELISA Kit (AC3852) Quantitative inquiry ASET-1036 Mouse TIMP1 ELISA Kit (AC2447) Quantitative inquiry ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry ASET-1234 Rat beta Catenin ELISA Kit (AC2645) Quantitative inquiry ASET-2208 Human Homer1 ELISA Kit (AC3619) Quantitative inquiry ASET-2447 Human Neuropilin 1 ELISA Kit (AC3858) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket